Detection Of Neoplastic Tissue in Barrett's Esophagus With In vivO Probe-based Confocal Endomicroscopy (DONTBIOPCE)
Barrett Syndrome, Barrett's Syndrome, Barrett's Esophagus
About this trial
This is an interventional diagnostic trial for Barrett Syndrome focused on measuring Barrett's Esophagus, EsoGastroDuodenoscopy, Barrett's Carcinoma, adenocarcinoma, Cellvizio, endomicroscopy, random biopsy
Eligibility Criteria
Inclusion Criteria:
- Patients with documented or suspected Barrett's esophagus presenting for endoscopy
- Age > 18 years
- Ability to provide written, informed consent
Exclusion Criteria:
- Presence of erosive esophagitis
- Inability to obtain biopsies due to anticoagulation, varices, etc.
- Allergy to fluorescein, pregnancy
- Presence of an esophageal mass other than small 10mm or less nodules
- Renal insufficiency
Sites / Locations
- Mayo Clinic
- Veterans Affairs Hospital
- New York Presbyterian Hospital/Columbia University Medical Center
- Centre Hospitalier Universitaire
- Klinikum rechts der Isar
Arms of the Study
Arm 1
Arm 2
Other
Other
Imaging Procedures HDWLE first NBI second and pCLE
Imaging Procedures NBI first HDWLE second and pCLE
All patients undergo both endoscopic imaging procedures and then the endomicroscopy procedure; the endoscopic imaging procedures being performed back to back by two endoscopists, blinded to each other.
All patients undergo both endoscopic imaging procedures and then the endomicroscopy procedure; the endoscopic imaging procedures being performed back to back by two endoscopists, blinded to each other.